2024 Fall Conference | C14 - Neurological Debate: Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy?

Date Saturday 10/26/24

Time 10:00 AM - 11:30 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Topic(s) Epilepsy/Clinical Neurophysiology (EEG), General Neurology

Learning Objectives By the end of this program, participants should be able to identify the clinical criteria for diagnosing epilepsy in patients with a single unprovoked seizure; evaluate the risks and benefits of treating patients with a single unprovoked seizure as if they have epilepsy; discuss the latest evidence and guidelines regarding the management of patients with a single unprovoked seizure; and formulate individualized treatment plans for patients presenting with a single unprovoked seizure, considering patient-specific factors and preferences.

CME Available 1.50 CME credits

Core Competencies Medical Knowledge

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
10:00 AM - 10:45 AM PDT	Speaker	Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy? (yes) Gregory D. Cascino, MD, FAAN
10:45 AM - 11:30 AM PDT	Speaker	Should Patients with a Single Unprovoked Seizure be Evaluated and Treated as if They Have Epilepsy? (no) Anteneh M. Feyissa, MD, MSc, FAAN

Faculty Disclosures
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Anteneh M. Feyissa, MD, MSc, FAAN	Dr. Feyissa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis.

��ɫ��

��ɫ��